Preclinical validations of [18F]FPyPEGCBT-c(RGDfK): a 18F-labelled RGD peptide prepared by ligation of 2-cyanobenzothiazole and 1,2-aminothiol to image angiogenesis
Authors (first, second and last of 4)
Volume 1, issue 1, January 2017
15 articles in this issue
-
-
Automation of the Radiosynthesis of Six Different 18F-labeled radiotracers on the AllinOne
Authors (first, second and last of 4)
-
Bone targeting compounds for radiotherapy and imaging: *Me(III)-DOTA conjugates of bisphosphonic acid, pamidronic acid and zoledronic acid
Authors (first, second and last of 4)
-
-
-
-
Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy
Authors (first, second and last of 9)
-
44Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations
Authors (first, second and last of 8)
-
Improved GMP-compliant multi-dose production and quality control of 6-[18F]fluoro-L-DOPA
Authors (first, second and last of 8)
-
-
Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics
Authors (first, second and last of 7)
-
DATATOC: a novel conjugate for kit-type 68Ga labelling of TOC at ambient temperature
Authors (first, second and last of 4)
-
Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission
Authors (first, second and last of 12)
-
-
Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals
Authors (first, second and last of 9)
